CHATSWORTH, Calif.--(BUSINESS WIRE)--CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the first quarter of fiscal 2008.
First Quarter Results
For the three months ended June 30, 2007, revenue declined to $3,973,000 from $5,476,000 for the first quarter of fiscal 2007, reflecting continued price pressure and lower domestic sales of oxygen conservers and transfilling systems as a result of Medicare-related reimbursement changes, as well as lower international sales of oxygen conservers.
